FAKTOR-OPTIONSSCHEIN - BRISTOL-MYERS SQUIBB | Market Closed - Deutsche Boerse AG 20:45:36 10/06/2024 BST | ||
| 1.23 EUR | -17.45% |
|
| Current month | -8.02% | ||
| 1 month | +35.45% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 10/06/24 | 1.23 | -17.45% |
| 07/06/24 | 1.49 | -6.29% |
| 06/06/24 | 1.59 | +3.92% |
| 05/06/24 | 1.53 | +7.75% |
| 04/06/24 | 1.42 | +2.90% |
Delayed Quote Deutsche Boerse AG
Last update June 10, 2024 at 08:45 pm
More quotesStatic data
| Product type | Exotische Produkte |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
Société Générale
|
| WKN | SB0XYT |
| ISIN | DE000SB0XYT8 |
| Date issued | 08/06/2020 |
| Strike | 60.88 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 8.88 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 16.54 € |
|---|---|
| Lowest since issue | 0.09 € |
| Spread | 0.01 € |
| Spread % | 0.80% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.48
USD
Average target price
53.19
USD
Spread / Average Target
+28.24%
- Stock Market
- Certificates
- Certificat
